Mifepristone and Misoprostol Versus Misoprostol Alone for Mid-Trimester Termination of Pregnancy (14 - 21 Weeks LMP): A Randomized-Controlled Double-Blinded Trial

Trial Profile

Mifepristone and Misoprostol Versus Misoprostol Alone for Mid-Trimester Termination of Pregnancy (14 - 21 Weeks LMP): A Randomized-Controlled Double-Blinded Trial

Completed
Phase of Trial: Phase III

Latest Information Update: 02 Apr 2010

At a glance

  • Drugs Mifepristone (Primary) ; Misoprostol
  • Indications Induced abortion
  • Focus Therapeutic Use
  • Most Recent Events

    • 09 Oct 2009 Status changed from recruiting to completed based on results reported.
    • 09 Oct 2009 Results presented at the 19th FIGO World Congress of Gynecology and Obstetrics.
    • 17 Nov 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top